Intellia's in vivo CRISPR therapy first to succeed in Phase 3

April 27, 2026 07:01 AM EDTUpdated 07:33 AM R&DCell/Gene Tx In­tel­li­a's in vi­vo CRISPR ther­a­py first to suc­ceed in Phase 3 Lei Lei Wu News Reporter Ryan Cross Senior Science Correspondent An ex­per­i­men­tal treat­ment that us­es CRISPR to ed­it genes di­rect­ly in­side the body has just suc­ceed­ed in a Phase 3 tri­al — a first for the … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER